Daiken Medical Co., Ltd. (TYO:7775)
Japan · Delayed Price · Currency is JPY 421.00
+1.00 (0.24%)
Aug 5, 2026, 3:30 PM JST
Daiken Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 1,246 | 1,508 | 1,436 | 1,025 | 1,151 |
Depreciation & Amortization | 258 | 232 | 214 | 267 | 314 |
Loss (Gain) From Sale of Assets | 28 | 2 | 5 | 28 | 1 |
Other Operating Activities | -374 | -445 | -436 | -377 | -219 |
Change in Accounts Receivable | -99 | 8 | 50 | -99 | 156 |
Change in Inventory | -161 | 7 | 76 | 29 | -122 |
Change in Accounts Payable | -294 | -126 | 120 | 113 | -71 |
Change in Other Net Operating Assets | -37 | -66 | 90 | 3 | -77 |
Operating Cash Flow | 567 | 1,120 | 1,555 | 989 | 1,133 |
Operating Cash Flow Growth | -49.38% | -27.97% | 57.23% | -12.71% | 86.04% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -327 | -166 | -162 | -198 | -202 |
Sale (Purchase) of Intangibles | - | -1 | -6 | -1 | - |
Other Investing Activities | -3 | -1 | - | -11 | 6 |
Investing Cash Flow | -330 | -168 | -168 | -210 | -196 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 200 | - | 80 | - | - |
Long-Term Debt Issued | 500 | 750 | - | 400 | 700 |
Total Debt Issued | 700 | 750 | 80 | 400 | 700 |
Short-Term Debt Repaid | - | -360 | - | - | - |
Long-Term Debt Repaid | -489 | -465 | -659 | -604 | -704 |
Total Debt Repaid | -489 | -825 | -659 | -604 | -704 |
Net Debt Issued (Repaid) | 211 | -75 | -579 | -204 | -4 |
Common Dividends Paid | -660 | -612 | -573 | -565 | -574 |
Other Financing Activities | -6 | -9 | -11 | -12 | -11 |
Financing Cash Flow | -455 | -696 | -1,163 | -781 | -589 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 1 | - | -2 | - | -1 |
Net Cash Flow | -217 | 256 | 222 | -2 | 347 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 240 | 954 | 1,393 | 791 | 931 |
Free Cash Flow Growth | -74.84% | -31.51% | 76.11% | -15.04% | 210.33% |
Free Cash Flow Margin | 2.33% | 9.59% | 14.29% | 8.66% | 10.90% |
Free Cash Flow Per Share | 8.35 | 33.21 | 48.49 | 27.53 | 32.41 |
Levered Free Cash Flow | 169.63 | 776.38 | 1,261 | 776.5 | 802.5 |
Unlevered Free Cash Flow | 177.13 | 782 | 1,264 | 778.38 | 804.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 12 | 10 | 4 | 3 | 3 |
Cash Income Tax Paid | 372 | 443 | 438 | 379 | 218 |
Change in Working Capital | -591 | -177 | 336 | 46 | -114 |